Answers are grounded in this paper and cite their sources.
Chronic kidney disease (CKD) affects more than 700 million individuals worldwide, and its complications extend across specialties. While dermatologic manifestations are estimated to affect nearly all patients with CKD, they remain significantly under-recognized and under-treated. These issues can be profoundly distressing for patients, significantly impacting their quality of life. Prompt diagnosis and treatment are essential for improving outcomes and reducing morbidity and mortality. However, dermatologic complications of CKD can be difficult to manage as many may present similarly and lack standardized guidelines. Moreover, varying cutaneous manifestations can be observed from early to late stages of kidney disease with progression of clinical features as disease worsens. Dermatologic manifestations may act as a sentinel sign for progression of internal disease. Therefore, better understanding of clinical characteristics of dermatologic complications is of particular importance in patients with kidney disease to allow for prompt diagnosis, further prevention and effective management. In this review, we discuss the epidemiology, risk factors, clinical features, diagnosis, management and prognosis of both common and life-threatening dermatologic complications of kidney disease, including CKD-associated pruritus (CKD-aP), uremic xerosis, uremic frost, porphyria cutanea tarda (PCT), acquired perforating dermatoses (APD), calcinosis cutis (CC), calciphylaxis, nephrogenic systemic fibrosis (NSF), pigmentary changes, and nail and hair changes.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: